These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35652502)

  • 1. Targeted mitochondrial drugs for treatment of myocardial ischaemia-reperfusion injury.
    Peng JF; Salami OM; Lei C; Ni D; Habimana O; Yi GH
    J Drug Target; 2022 Sep; 30(8):833-844. PubMed ID: 35652502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria-targeted cyclosporin A delivery system to treat myocardial ischemia reperfusion injury of rats.
    Zhang CX; Cheng Y; Liu DZ; Liu M; Cui H; Zhang BL; Mei QB; Zhou SY
    J Nanobiotechnology; 2019 Jan; 17(1):18. PubMed ID: 30683110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial targeted astaxanthin liposomes for myocardial ischemia-reperfusion injury based on oxidative stress.
    Gao F; Zhao Y; Zhang B; Xiao C; Sun Z; Gao Y; Dou X
    J Biomater Appl; 2022 Aug; 37(2):303-314. PubMed ID: 35403475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of mitochondrial dynamics modulators in cardiac ischaemia/reperfusion injury.
    Maneechote C; Palee S; Chattipakorn SC; Chattipakorn N
    J Cell Mol Med; 2017 Nov; 21(11):2643-2653. PubMed ID: 28941171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tongmai formula improves cardiac function via regulating mitochondrial quality control in the myocardium with ischemia/reperfusion injury.
    Zhao Y; Guo R; Li L; Li S; Fan G; Zhao X; Wang Y
    Biomed Pharmacother; 2020 Dec; 132():110897. PubMed ID: 33113431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of G protein-coupled oestrogen receptor 1 at the onset of reperfusion protects the myocardium against ischemia/reperfusion injury by reducing mitochondrial dysfunction and mitophagy.
    Feng Y; Madungwe NB; da Cruz Junho CV; Bopassa JC
    Br J Pharmacol; 2017 Dec; 174(23):4329-4344. PubMed ID: 28906548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered FoF1 ATP synthase and susceptibility to mitochondrial permeability transition pore during ischaemia and reperfusion in aging cardiomyocytes.
    Fernandez-Sanz C; Ruiz-Meana M; Castellano J; Miro-Casas E; Nuñez E; Inserte J; Vázquez J; Garcia-Dorado D
    Thromb Haemost; 2015 Mar; 113(3):441-51. PubMed ID: 25631625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial quality control in cardiac ischemia/reperfusion injury: new insights into mechanisms and implications.
    Bai Y; Wu J; Yang Z; Wang X; Zhang D; Ma J
    Cell Biol Toxicol; 2023 Feb; 39(1):33-51. PubMed ID: 35951200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of natural products against myocardial ischemia/reperfusion: Mitochondria-targeted therapeutics.
    Su X; Zhou M; Li Y; Zhang J; An N; Yang F; Zhang G; Yuan C; Chen H; Wu H; Xing Y
    Biomed Pharmacother; 2022 May; 149():112893. PubMed ID: 35366532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural apelin analogues: mitochondrial ROS inhibition and cardiometabolic protection in myocardial ischaemia reperfusion injury.
    Pisarenko O; Shulzhenko V; Studneva I; Pelogeykina Y; Timoshin A; Anesia R; Valet P; Parini A; Kunduzova O
    Br J Pharmacol; 2015 Jun; 172(12):2933-45. PubMed ID: 25521429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS.
    Chouchani ET; Pell VR; Gaude E; Aksentijević D; Sundier SY; Robb EL; Logan A; Nadtochiy SM; Ord ENJ; Smith AC; Eyassu F; Shirley R; Hu CH; Dare AJ; James AM; Rogatti S; Hartley RC; Eaton S; Costa ASH; Brookes PS; Davidson SM; Duchen MR; Saeb-Parsy K; Shattock MJ; Robinson AJ; Work LM; Frezza C; Krieg T; Murphy MP
    Nature; 2014 Nov; 515(7527):431-435. PubMed ID: 25383517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cardioprotective actions of statins in targeting mitochondrial dysfunction associated with myocardial ischaemia-reperfusion injury.
    Bland AR; Payne FM; Ashton JC; Jamialahmadi T; Sahebkar A
    Pharmacol Res; 2022 Jan; 175():105986. PubMed ID: 34800627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-ischaemic mitochondrial substrate constraint by inhibition of malate-aspartate shuttle preserves mitochondrial function after ischaemia-reperfusion.
    Jespersen NR; Yokota T; Støttrup NB; Bergdahl A; Paelestik KB; Povlsen JA; Dela F; Bøtker HE
    J Physiol; 2017 Jun; 595(12):3765-3780. PubMed ID: 28093764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitophagy imbalance in cardiomyocyte ischaemia/reperfusion injury.
    Li YZ; Wu XD; Liu XH; Li PF
    Acta Physiol (Oxf); 2019 Apr; 225(4):e13228. PubMed ID: 30507035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of mitochondria in protection of the heart by preconditioning.
    Halestrap AP; Clarke SJ; Khaliulin I
    Biochim Biophys Acta; 2007 Aug; 1767(8):1007-31. PubMed ID: 17631856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic disarrangement in ischemic heart disease and its therapeutic control.
    Ferrari R
    Rev Port Cardiol; 1998 Sep; 17(9):667-84. PubMed ID: 9834638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial oxidative phosphorylation and mitophagy in myocardial ischaemia/reperfusion: effects of chloroquine.
    Dhanabalan K; Huisamen B; Lochner A
    Cardiovasc J Afr; 2020; 31(4):169-179. PubMed ID: 31995116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitophagy and mitochondrial integrity in cardiac ischemia-reperfusion injury.
    Yang M; Linn BS; Zhang Y; Ren J
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2293-2302. PubMed ID: 31100337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondria-targeted antioxidant delivery for precise treatment of myocardial ischemia-reperfusion injury through a multistage continuous targeted strategy.
    Cheng Y; Liu DZ; Zhang CX; Cui H; Liu M; Zhang BL; Mei QB; Lu ZF; Zhou SY
    Nanomedicine; 2019 Feb; 16():236-249. PubMed ID: 30639669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice lacking the glutamate-cysteine ligase modifier subunit are susceptible to myocardial ischaemia-reperfusion injury.
    Kobayashi T; Watanabe Y; Saito Y; Fujioka D; Nakamura T; Obata JE; Kitta Y; Yano T; Kawabata K; Watanabe K; Mishina H; Ito S; Kugiyama K
    Cardiovasc Res; 2010 Mar; 85(4):785-95. PubMed ID: 19837697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.